# WAYRILZ
> **NDA219685** · New Drug Application · Sponsor: GENZYME CORP · Approved 2025-08-29
## Drug
- **FDA Application Number:** NDA219685
- **Application type:** New Drug Application
- **Brand name:** WAYRILZ
- **Generic name:** RILZABRUTINIB
- **Active ingredients:** RILZABRUTINIB
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** GENZYME CORP
- **Manufacturer:** Genzyme Corporation
- **First approval:** 2025-08-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219685)
---
*AI Analytics · CC0 1.0*